Who are BIOVECTRA's investors?

BIOVECTRA's investors include H.I.G. Capital, H.I.G. HealthBridge Partners.

BIOVECTRA

2 known investors

Find your way into BIOVECTRA

Paths you didn't know you had: your email and LinkedIn already hold routes to the BIOVECTRA team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.

Advanced Manufacturing Biotech Healthtech

Investors · 2

H.I.G. Capitallisted by H.I.G. CapitalMiami

H.I.G. HealthBridge Partnerslisted by H.I.G. HealthBridge PartnersMiami · $5M – $40M

How we know: H.I.G. HealthBridge Partners's portfolio page · Not right? Tell us

Frequently asked questions

What does BIOVECTRA do?: BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.
Who are BIOVECTRA's investors?: BIOVECTRA's investors include H.I.G. Capital, H.I.G. HealthBridge Partners.